| Dr Nutan Bhaskar, MD | |
|
415 W Carroll Ave Ste 100, Glendora, CA 91741-4208 | |
| (626) 914-5219 | |
| Not Available |
| Full Name | Dr Nutan Bhaskar |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 21 Years |
| Location | 415 W Carroll Ave Ste 100, Glendora, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922269604 | NPI | - | NPPES |
| 199127001 | Medicaid | AR | |
| 686501 | Other | AR | MEDICARE ID# FOR CHI ST. VINCENT LITTLE ROCK DIAGNOSTIC CLINIC |
| 299485 | Other | AR | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | E7721 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emanate Health Inter-community Hospital | Covina, CA | Hospital |
| San Antonio Regional Hospital | Upland, CA | Hospital |
| Emanate Health Foothill Presbyterian Hospital | Glendora, CA | Hospital |
| Montclair Hospital Medical Center | Montclair, CA | Hospital |
| Chino Valley Medical Center | Chino, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group | 5698758803 | 139 |
| California Pulmonary Associates Inc | 6608272455 | 7 |
News Archive
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's Research.
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
PBS NewsHour reports on some states with GOP governors who opposed the health law but want to pursue the Medicaid expansion. In one such state, Arizona, the Republican governor signed expansion legislation after a bruising fight with conservatives in the legislature. But, in Maine, the governor vetoed such a measure for the second time while news outlets offer updates from Virginia, Michigan and Ohio.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
› Verified 5 days ago
| Entity Name | Jefferson Hospital Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932157674 PECOS PAC ID: 8123927431 Enrollment ID: O20040106000512 |
News Archive
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's Research.
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
PBS NewsHour reports on some states with GOP governors who opposed the health law but want to pursue the Medicaid expansion. In one such state, Arizona, the Republican governor signed expansion legislation after a bruising fight with conservatives in the legislature. But, in Maine, the governor vetoed such a measure for the second time while news outlets offer updates from Virginia, Michigan and Ohio.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
› Verified 5 days ago
| Entity Name | Little Rock Diagnostic Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497784854 PECOS PAC ID: 8820985138 Enrollment ID: O20040302000483 |
News Archive
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's Research.
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
PBS NewsHour reports on some states with GOP governors who opposed the health law but want to pursue the Medicaid expansion. In one such state, Arizona, the Republican governor signed expansion legislation after a bruising fight with conservatives in the legislature. But, in Maine, the governor vetoed such a measure for the second time while news outlets offer updates from Virginia, Michigan and Ohio.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
› Verified 5 days ago
| Entity Name | St Vincent Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134176480 PECOS PAC ID: 5698758803 Enrollment ID: O20040622000224 |
News Archive
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's Research.
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
PBS NewsHour reports on some states with GOP governors who opposed the health law but want to pursue the Medicaid expansion. In one such state, Arizona, the Republican governor signed expansion legislation after a bruising fight with conservatives in the legislature. But, in Maine, the governor vetoed such a measure for the second time while news outlets offer updates from Virginia, Michigan and Ohio.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
› Verified 5 days ago
| Entity Name | St Vincent Infirmary Medical Center |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1356817910 PECOS PAC ID: 5698674166 Enrollment ID: O20190520000424 |
News Archive
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's Research.
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
PBS NewsHour reports on some states with GOP governors who opposed the health law but want to pursue the Medicaid expansion. In one such state, Arizona, the Republican governor signed expansion legislation after a bruising fight with conservatives in the legislature. But, in Maine, the governor vetoed such a measure for the second time while news outlets offer updates from Virginia, Michigan and Ohio.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nutan Bhaskar, MD 154a W Foothill Blvd # 281, Upland, CA 91786-3847 Ph: (626) 914-5219 | Dr Nutan Bhaskar, MD 415 W Carroll Ave Ste 100, Glendora, CA 91741-4208 Ph: (626) 914-5219 |
News Archive
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, today announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like peptide-1 (GLP-1) analogue originating from Ipsen's Research.
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
PBS NewsHour reports on some states with GOP governors who opposed the health law but want to pursue the Medicaid expansion. In one such state, Arizona, the Republican governor signed expansion legislation after a bruising fight with conservatives in the legislature. But, in Maine, the governor vetoed such a measure for the second time while news outlets offer updates from Virginia, Michigan and Ohio.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
› Verified 5 days ago
Adel Sandouk, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 210 S Grand Ave Ste 307, Glendora, CA 91741 Phone: 626-914-2900 | |
Adam Jonathan Snyder, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 415 W Route 66 Ste 102, Glendora, CA 91740 Phone: 626-610-2112 | |
William Kurban, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 210 S Grand Ave Ste 224, Glendora, CA 91741 Phone: 626-335-8094 | |
Dr. Jaspreet S Ahuja, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 353 W Foothill Blvd, Glendora, CA 91741 Phone: 626-914-5219 | |
Cristina G Christopher, PAC Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 640 W Foothill Blvd, Suite 100, Glendora, CA 91741 Phone: 626-335-4041 Fax: 626-335-3768 | |
Mr. Oliver M Solomon, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 West Route 66, Suite 326, Glendora, CA 91740 Phone: 626-963-8588 Fax: 626-968-8578 | |
Dr. Robert Morgan, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 260 Cimmeron Trl, Glendora, CA 91741 Phone: 626-914-1399 |